相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV
S. R. Singh et al.
GENE THERAPY (2009)
Anti-angiogenic effects of non-peptide integrin αvβ3 specific antagonist on laser-induced choroidal neovascularization in mice
Shigeru Honda et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
The promise of nanomedicine for ocular disease
Heather Thomson et al.
NANOMEDICINE (2009)
CCR3 is a target for age-related macular degeneration diagnosis and therapy
Atsunobu Takeda et al.
NATURE (2009)
Antiangiogenic Approaches to Age-Related Macular Degeneration Today
Neil M. Bressler
OPHTHALMOLOGY (2009)
Expression of integrins in human proliferative diabetic retinopathy membranes
Aflison Ning et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2008)
Medical progress: Age-related macular degeneration
Rama D. Jager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Endogenous endostatin inhibits choroidal neovascularization
Alexander G. Marneros et al.
FASEB JOURNAL (2007)
Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization
Haicheng She et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization
Hadi J. Zambarakji et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Nanotechnology for antiangiogenic cancer therapy
Hanako Kobayashi et al.
NANOMEDICINE (2006)
Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration
J Gaudreault et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
2002 global update of available data on visual impairment:: a compilation of population-based prevalence studies
D Pascolini et al.
OPHTHALMIC EPIDEMIOLOGY (2004)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2
RZ Renno et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1
KJ Blinder et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization
E Sakurai et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Tumor regression by targeted gene delivery to the neovasculature
JD Hood et al.
SCIENCE (2002)
The αvβ3 integrin, NF-κB, osteoprotegerin endothelial cell survival pathway -: Potential role in angiogenesis
MT Scatena et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
MEK kinase activity is not necessary for Raf-1 function
M Hüser et al.
EMBO JOURNAL (2001)
分享论文
